Medifast, inc. announces $100m accelerated share repurchase program

Investment demonstrates confidence in long-term growth model, aligns interests with stockholders baltimore , june 1, 2022 /prnewswire/ -- medifast, inc (nyse: med), the global company behind one of the fastest-growing health and wellness communities, optavia® , announced today it has entered into an accelerated share repurchase agreement ("asr") with jpmorgan chase, national association ("jpm"), to repurchase an aggregate of $100 million of the company's common stock. this equates to approximately 600,000 shares, at the closing price on may 31, 2022, and represents approximately 5% of the company's fully diluted outstanding stock.
MED Ratings Summary
MED Quant Ranking